Skip to main content
    P

    Prenetics Global Ltd (PRE)

    Official site

    CONSUMER DEFENSIVE • DIAGNOSTICS & RESEARCH • NASDAQ

    $20.26
    -0.34 (-1.65%)

    Market Cap: $415.07M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(9/18)
    Avg Surprise
    -158.51%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.99
    Range$-1.51 - $-0.51
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.42-136.5%
    60d ago$-0.42-136.5%
    30d ago$-1.01+1.7%
    7d ago$-0.990.0%
    Current$-0.99
    Revenue Consensus
    $63M
    Range$63M - $64M
    7 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-1.12
    Range$-1.61 - $-0.63
    2 analysts
    Revenue Consensus
    $75M
    Range$71M - $77M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.12---
    Sep 26EST
    		-$-0.99---
    Jun 26
    Reported Aug 18
    		$-0.53$-0.32-65.63%Miss+43.6%
    Mar 26
    Reported Jun 10
    		$-0.56$-0.49-14.29%Miss+30.0%
    Dec 25
    Reported Feb 18
    		$-0.27$-0.49+44.90%Beat+79.1%
    Sep 25
    Reported Nov 10
    		$-0.53$-0.55+3.64%Beat+36.9%
    Jun 25
    Reported Sep 12
    		$-0.94$-0.71-32.39%Miss-6.8%
    Mar 25
    Reported Jun 12
    		$-0.80$-0.80+0.00%Beat+84.9%
    Dec 24
    Reported Mar 5
    		$-1.29$-0.72-79.17%Miss+17.8%
    Sep 24
    Reported Nov 27
    		$-0.84$-0.86+2.33%Beat+30.0%
    Jun 24
    Reported Sep 27
    		$-0.88$-0.93+5.38%Beat-780.0%
    Mar 24
    Reported Jun 18
    		$-5.30$-4.80-10.42%Miss-404.8%
    Dec 23
    Reported Mar 26
    		$-1.57$-0.05-3040.00%Miss-1146.7%
    Sep 23
    Reported Nov 20
    		$-1.20$-1.20+0.00%Beat-126.9%
    Jun 23
    Reported Sep 15
    		$-0.10$-0.05-100.00%Miss-350.0%
    Mar 23
    Reported Jun 5
    		$-1.05$-0.75-40.00%Miss+96.8%
    Dec 22
    Reported Mar 14
    		$0.15N/A+110.00%Beat+3.8%
    Sep 22
    Reported Nov 10
    		$4.46$-1.95+328.72%Beat+5055.6%
    Jun 22
    Reported Sep 9
    		$0.04N/A+106.45%Beat+130.8%
    Mar 22
    Reported May 17
    		$-33.15$-19.20-72.66%Miss-
    Dec 21
    Reported Mar 4
    		$0.14N/AN/ABeat-
    Sep 21
    Reported Nov 15
    		$-0.09N/AN/ABeat-
    Jun 21
    Reported Aug 16
    		$-0.13$0.00N/AMiss-
    Mar 21
    Reported Jun 29
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-10.72EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-30.40%Operating Margin-45.10%
    ROE-47.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-546.51x
    Current Ratio4.04xQuick Ratio3.66x
    Trading Statistics
    Beta0.35Avg Volume188.55K
    52-Week High$27.2452-Week Low$11.37

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$21.11
    SMA 20$22.09
    SMA 50$22.24
    SMA 200$19.48
    EMA 10$21.28
    EMA 20$21.83
    EMA 50$21.84
    EMA 200$19.01

    MACD

    Line: -0.55Signal: -0.35Hist: -0.21

    ADX

    ADX: 14.4+DI: 16.0-DI: 20.8

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down72.0
    PSAR$22.65

    Bollinger Bands

    Upper Band$24.57
    Lower Band$19.61
    %B Position2246%(Upper)
    Band Width0.13

    RSI (14-Day)

    Neutral
    39.8

    Momentum Oscillators

    Stoch %K23.3
    Stoch %D31.5
    Williams %R-88.1
    ROC (10d)-7.7%
    Momentum-1.69
    CCI (20d)-111.8
    MFI (14d)44.3

    Volatility Measures

    ATR (14d)$1.40(6.9%)
    StdDev (20d)1.24
    Hist Vol60.0%(High)

    Volume Flow

    VWAP$20.44
    OBV3.4M
    AD Line2.6M
    CMF (20d)-0.190

    Volume Metrics

    Avg Vol (20d)181.1K
    Vol Ratio0.5x
    VWMA (20d)$21.94

    Pivot Points

    R3$22.60
    R2$22.12
    R1$21.36
    Pivot Point$20.88
    S1$20.12
    S2$19.64
    S3$18.88

    Advanced Oscillators

    TSI-11.49
    Ultimate Osc48.2
    KST-69.72

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$46.49M$35.95M$36.56M$23.55M$17.68M$10.49M$10.49M$7.78M$5.94M$6.41M$5.43M$4.88M
    Cost of Revenue$16.29M$12.67M$14.82M$9.53M$10.39M$6.59M$6.59M$3.83M$2.17M$2.63M$2.76M$3.22M
    Gross Profit$30.20M$23.28M$21.74M$14.02M$7.29M$3.90M$3.90M$3.95M$3.77M$3.78M$2.67M$1.65M
    Operating Expenses$52.12M$32.99M$34.13M$20.19M$17.35M$20.47M$28.35M$15.76M$14.38M$12.94M$14.86M$14.60M
    R&D$757,000$1.44M$742,999$1.17M$1.21M$2.58M$2.58M$2.59M$3.03M$2.73M$2.59M$4.00M
    SG&A$10.06M$9.34M$14.62M$9.55M$10.49M$16.78M$19.18M$11.20M$9.69M$9.06M$10.36M$10.56M
    Operating Income$-21,919,000$-9,706,000$-12,391,000$-6,164,000$-10,065,000$-16,567,805$-17,861,421$-11,808,320$-10,608,960$-9,160,000$-12,187,090$-12,943,513
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$13,000$9,000$44,999$55,000$65,000$78,630$78,630$80,552$27,479$16,000$31,610$35,492
    Income Before Tax$-9,083,000$-27,308,000$-28,370,000$-6,779,000$-10,954,000$-24,968,782$-24,968,782$-12,113,174$-11,130,664$-9,311,000$-17,889,556$-11,997,699
    Income Tax Expense$4,999$28,000$42,999$9,000$-33,000$-7,423,521$0$-75,307$89,233$-286,000$10,678$-11,544
    Net Income$-8,983,000$-23,104,000$-28,115,000$-7,408,000$-12,410,000$-16,341,715$-16,341,715$-10,672,236$-10,721,954$-8,568,000$-19,047,124$-13,570,455
    EBITDA$-21,727,000$-9,522,000$-24,543,000$-6,724,000$-10,889,000$-24,890,152N/A$34,378$-7,624,482$-9,295,000$-11,877,280$-11,962,207
    EBIT$-21,919,000$-9,706,000$-28,325,000$-6,724,000$-8,379,000N/AN/A$-12,032,622$-11,103,185$-14,670,336$-12,187,092$-12,748,548
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PRE

    News

    Form 4 Prenetics Global Ltd For: 6 October By Investing.com

    The article reports on a Form 4 filing for Prenetics Global Ltd on October 6, 2026. It is a brief financial news item from Investing.com...

    Investing.com Nigeria•10/6/26•Neutral

    Form 4 Prenetics Global Ltd For: 6 October By Investing.com

    This article from Investing.com is a standard SEC Form 4 filing for Prenetics Global Ltd, dated October 6. Form 4 is used to report changes in beneficial ownership of a company's securities by its directors, officers...

    Investing.com Canada•10/6/26•Neutral

    A 2,000-share grant settlement leaves Prenetics Global (PRE) director holding 8,001 shares.

    Prenetics Global director Hudson Blake Leogrande received 2,000 Class A Ordinary Shares from the settlement of vested Restricted Stock Units (RSUs) on October 4, 2026. These RSUs...

    Stock Titan•10/6/26•Neutral

    After acquiring 7,635 shares, Prenetics (PRE) CFO Hoi Chun Lo holds 573,648 shares.

    Prenetics Global Ltd's CFO, Hoi Chun Lo, reported the acquisition of 7,635 Class A ordinary shares through the exercise or conversion of Restricted Stock Units (RSUs) on September 30, 2026. Following this transaction...

    Stock Titan•10/2/26•Neutral

    Prenetics Global Ltd (PRE) discloses new private share and warrant deals

    Prenetics Global Ltd (PRE) filed an F-1/A amendment to add auditor consents and detail unregistered issuances of Class A Ordinary Shares and Class C warrants since January 2023. These issuances were for acquisitions...

    Stock Titan•9/22/26•Neutral

    PRE Valuation and Fair Value

    P/E
    -10.7x
    PEG
    0.0x
    P/B
    3.8x
    See GNG's fair value

    PRE Profitability: Margins, ROIC and FCF

    Gross margin
    62.6%
    Operating margin
    -45.1%
    Net margin
    -30.4%
    ROE
    -47.0%
    FCF margin
    -49.5%

    PRE Competitors

    CompanyTicker
    Community Health Systems IncCYH
    DiaMedica Therapeutics IncDMAC
    Zura Bio Limited Class A Ordinary SharesZURA
    Tectonic Therapeutic, Inc.TECX
    Ovid Therapeutics IncOVID
    Rezolute IncRZLT
    Cross Country Healthcare IncCCRN
    Avita Medical LtdRCEL

    Sector: Healthcare

    PRE Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    0
    Buy
    5
    Hold
    0
    Sell
    0
    Strong Sell
    0

    PRE Bull Case vs Bear Case

    Bull case

    • PRE grew quarterly revenue 210.7% year over year.
    • 100.0% of PRE's analyst ratings are Buy or Strong Buy.

    Bear case

    • PRE has a -30.4% net profit margin.
    • PRE beat EPS estimates in 37.5% of its last 8 reported quarters.

    PRE Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -17.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.99
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About PRE

    Does PRE pay dividends?

    Prenetics Global Ltd (PRE) does not currently pay a regular dividend.

    What is PRE's market cap?

    Prenetics Global Ltd (PRE) has a market capitalization of $415.07M with a current stock price of $20.26.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In